Reports First-Quarter Diluted EPS of $2.51 on a GAAP Basis, an Increase of 26.1 Percent; Adjusted Diluted EPS of $3.16, an Increase of 9.3 Percent; These.
/PRNewswire/ AbbVie (NYSE:ABBV) announced financial results for the fourth quarter and full year ended December 31, 2021. "We delivered another year of.